The proposal describes four specific aims which will test the ultrafast
responses of native rhodopsin and rhodopsin analogues using visible,
near, and mid infrared spectroscopy.
The first specific aim concerns isotope effects on the ultrafast
processes involved in isomerization. The candidate will utilize an
ultrafast laser system with 35 fs resolution to monitor the dynamics of
the initially-produced intermediates involved in the primary processes
of isomerization. Theses experiments will test the possibility that local
charge density surrounding retinal controls the dynamics of
isomerization. If this is so, then a proton transfer, which may precede
retinal isomerization, would change the charge density in the vicinity
of retinal and affect isomerization dynamics. The candidate should be
able to determine whether a proton shift or a change in hydrogen
bonding strength has occurred by correlating the dynamics of
isomerization, using visible light pulses, and proton shifting, using
infrared light pulses. These experiments are will-designed and should
provide valuable information.
In the second aim, the candidate, using short excitation/probe pulses,
will concentrate on following the isomerization process in real time in
the spectral region to the red of 650 nm and to the blue of 480 nm.
Recent results on bacteriorhodopsin, which has substantial homology
with rhodopsin, indicate that important information concerning the
kinetic signatures of intermediates crucial to the initial isomerization
process may be contained in these spectral regions. These well-
designed experiments should provide this information, as well as
determine from which electronically excited state isomerization occurs.
In the third specific aim, the candidate will use techniques developed
to monitor conformational changes of retinal during isomerization.
Specifically, she will use measurements of the vibrational
characteristics and dipole moment changes of retinal to track
isomerization in real time. The experiments are well-designed and
should provide a clearer picture of the dynamics of isomerization as
seen from changes in the anisotropy signal and vibrational spectra. In
addition, these results may provide insight into the relative
importance of the individual motions of specific substituents of retinal
of the initial isomerization process.
In the fourth specific aim, the candidate will use site directed
mutagenesis to modify specific amino acid residues that reside within
the cofactor binding pocket in rhodopsin. These experiments could
reveal whether particular sites on the opsin interact with the
cofactor. In fact, the candidate provides reasonable hypotheses with
respect to the possible important of two specific opsin amino acid
residues that she proposes to test. However, she does not explain how
mutations of these amino acid residues will be obtained, except to
state that various named individuals will develop these rhodopsin
mutants or supply the resources to do so. These individuals have not
provided letters of collaboration for this proposal, however. It is
therefore not clear whether this last specific aim will be successfully
performed.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
aminoacidchemical transfer reactioncofactorconformationelectronic spectrainfrared spectrometrylaser spectrometryphotoactivationphotochemistryprotein structure functionrhodopsinsite directed mutagenesis
No Sub Projects information available for 1F32EY006849-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F32EY006849-01
Patents
No Patents information available for 1F32EY006849-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F32EY006849-01
Clinical Studies
No Clinical Studies information available for 1F32EY006849-01
News and More
Related News Releases
No news release information available for 1F32EY006849-01
History
No Historical information available for 1F32EY006849-01
Similar Projects
No Similar Projects information available for 1F32EY006849-01